@article{3b85672c8d03463baefba1f43bc10ab7,
title = "Biofabrication of Hepatic Constructs by 3D Bioprinting of a Cell-Laden Thermogel: An Effective Tool to Assess Drug-Induced Hepatotoxic Response",
abstract = "A thermoresponsive Pluronic/alginate semisynthetic hydrogel is used to bioprint 3D hepatic constructs, with the aim to investigate liver-specific metabolic activity of the 3D constructs compared to traditional 2D adherent cultures. The bioprinting method relies on a bioinert hydrogel and is characterized by high-shape fidelity, mild depositing conditions and easily controllable gelation mechanism. Furthermore, the dissolution of the sacrificial Pluronic templating agent significantly ameliorates the diffusive properties of the printed hydrogel. The present findings demonstrate high viability and liver-specific metabolic activity, as assessed by synthesis of urea, albumin, and expression levels of the detoxifying CYP1A2 enzyme of cells embedded in the 3D hydrogel system. A markedly increased sensitivity to a well-known hepatotoxic drug (acetaminophen) is observed for cells in 3D constructs compared to 2D cultures. Therefore, the 3D model developed herein may represent an in vitro alternative to animal models for investigating drug-induced hepatotoxicity.",
keywords = "3D liver models, bioprinting, drug hepatotoxicity, hepatic constructs, Pluronic, alginate thermogels, ACETAMINOPHEN-INDUCED HEPATOTOXICITY, IN-VITRO MODEL, CYTOCHROME-P450 INDUCTION, HEPG2 CELLS, LIVER, CULTURE, TOXICITY, HEPATOCYTE, PREDICTION, MECHANISMS",
author = "Manuele Gori and Giannitelli, {Sara M.} and Miranda Torre and Pamela Mozetic and Franca Abbruzzese and Marcella Trombetta and Enrico Traversa and Lorenzo Moroni and Alberto Rainer",
note = "Funding Information: M.G. and S.M.G. contributed equally to this work. This work was partially supported by MIUR‐FIRB program (grant no. RBFR10L0GK). M.G. was supported by a Fellowship from FIRE “Fondazione Italiana per la Ricerca in Epatologia” Onlus (FIRE Fellowship 2017). P.M. acknowledges support from the European Social Fund and the European Regional Development Fund (CZ.02.1.01/0.0/0.0/15_003/0000492 “Unveiling the molecular determinants of aging to design new therapeutics ‐ MAGNET”). P.M., L.M. and A.R. are thankful to {"}Tecnopolo per la medicina di precisione{"} (TecnoMed Puglia) ‐ Regione Puglia: DGR n.2117 dated 21/11/2018, CUP: B84I18000540002 and {"}Tecnopolo di Nanotecnologia e Fotonica per la Medicina di Precisione{"} (TECNOMED) ‐ FISR/MIUR‐CNR: delibera CIPE n.3449 dated 07/08/2017, CUP: B83B17000010001. Funding Information: M.G. and S.M.G. contributed equally to this work. This work was partially supported by MIUR-FIRB program (grant no. RBFR10L0GK). M.G. was supported by a Fellowship from FIRE ?Fondazione Italiana per la Ricerca in Epatologia? Onlus (FIRE Fellowship 2017). P.M. acknowledges support from the European Social Fund and the European Regional Development Fund (CZ.02.1.01/0.0/0.0/15_003/0000492 ?Unveiling the molecular determinants of aging to design new therapeutics - MAGNET?). P.M., L.M. and A.R. are thankful to {"}Tecnopolo per la medicina di precisione{"} (TecnoMed Puglia) - Regione Puglia: DGR n.2117 dated 21/11/2018, CUP: B84I18000540002 and {"}Tecnopolo di Nanotecnologia e Fotonica per la Medicina di Precisione{"} (TECNOMED) - FISR/MIUR-CNR: delibera CIPE n.3449 dated 07/08/2017, CUP: B83B17000010001. Publisher Copyright: {\textcopyright} 2020 Wiley-VCH GmbH",
year = "2020",
month = nov,
doi = "10.1002/adhm.202001163",
language = "English",
volume = "9",
journal = "Advanced Healthcare Materials",
issn = "2192-2640",
publisher = "John Wiley & Sons Inc.",
number = "21",
}